Physician profile
Jon J Heeb
NPI 1285698431
$957.37
in general payments reported to CMS, 2019-2025
19 companies · $329 in 2025
The $329 reported for 2025 was less than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $98.22 · 2020: $24.86 · 2021: $106 · 2022: $43.23 · 2023: $263 · 2024: $92.49 · 2025: $329.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $685.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $685.19 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Axonics, INC. | $215.81 | 2022-2024 | Axonics, Bulkamid |
| Intuitive Surgical, INC. | $97.10 | 2020-2021 | |
| Procept Biorobotics Corporation | $94.93 | 2023-2025 | Aquabeam Robotic System |
| Coloplast Corp | $81.94 | 2019-2025 | |
| Sumitomo Pharma America, INC. | $63.45 | 2023-2025 | Gemtesa |
| Urogen Pharma, INC. | $62.09 | 2024-2025 | |
| C. R. Bard, INC. & Subsidiaries | $41.62 | 2025 | Bard Urinary Drainage Bag, Purewick Female External Catheter |
| Pfizer INC. | $40.19 | 2019-2025 | |
| Astellas Pharma US INC | $32.86 | 2019-2024 | Myrbetriq |
| Olympus America INC. | $32.84 | 2025 | Itind System |
| Boston Scientific Corporation | $32.11 | 2021-2025 | Axonics |
| Abbvie INC. | $30.35 | 2019 | |
| Travere Therapeutics, INC. | $24.48 | 2019 | |
| Caldera Medical, INC | $23.51 | 2025 | |
| Telix Pharmaceuticals | $22.14 | 2025 | Illuccix |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Tolmar, INC. | $17.61 | 2024 | |
| Laborie Medical Technologies Corp. | $17.32 | 2025 | |
| Endo Pharmaceuticals INC. | $13.83 | 2023 | Xiaflex |
| Urovant Sciences INC | $13.19 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jon Heeb listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.